Sign In
Buy SRRK
$44.64
-0.0400 (-0.0895%)
At Close: Jun 03, 2026
Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
09:30am, Tuesday, 26'th May 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additi
Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference
08:00am, Wednesday, 20'th May 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additi
Three Biotechs That Are Top Takeover Targets
01:55pm, Monday, 18'th May 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) is the stock everyone wants to talk about, and the reasons are obvious: Mounjaro revenue jumped 125% to $8.66 billion last quarter, the company raised full-
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 15'th May 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 38,481 shares of its common
Scholar Rock Holding Corporation (SRRK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:20pm, Tuesday, 12'th May 2026
Scholar Rock Holding Corporation (SRRK) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Scholar Rock Q1 Earnings Call Highlights
10:06pm, Friday, 08'th May 2026
Scholar Rock NASDAQ: SRRK said the U.S. Food and Drug Administration has accepted for review its resubmitted Biologics License Application for apitegromab, the company's investigational treatment for
Scholar Rock Holding Corporation (SRRK) Q1 2026 Earnings Call Transcript
03:01pm, Thursday, 07'th May 2026
Scholar Rock Holding Corporation (SRRK) Q1 2026 Earnings Call Transcript
Scholar Rock Reports First Quarter 2026 Financial Results and Recent Business Highlights
07:00am, Thursday, 07'th May 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additi
Scholar Rock to Present at the BofA Securities 2026 Health Care Conference
08:00am, Wednesday, 29'th Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additi
Scholar Rock (NASDAQ:SRRK) COO Keith Woods Sells 10,220 Shares
05:02am, Tuesday, 21'st Apr 2026
Scholar Rock Holding Corporation (NASDAQ: SRRK - Get Free Report) COO Keith Woods sold 10,220 shares of the business's stock in a transaction on Thursday, April 16th. The stock was sold at an average
Scholar Rock (NASDAQ:SRRK) Insider Akshay Vaishnaw Sells 12,246 Shares
05:02am, Tuesday, 21'st Apr 2026
Scholar Rock Holding Corporation (NASDAQ: SRRK - Get Free Report) insider Akshay Vaishnaw sold 12,246 shares of Scholar Rock stock in a transaction on Thursday, April 16th. The stock was sold at an av
Scholar Rock (NASDAQ:SRRK) CFO Vikas Sinha Sells 10,410 Shares of Stock
05:02am, Tuesday, 21'st Apr 2026
Scholar Rock Holding Corporation (NASDAQ: SRRK - Get Free Report) CFO Vikas Sinha sold 10,410 shares of the stock in a transaction on Thursday, April 16th. The shares were sold at an average price of
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:15pm, Friday, 17'th Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 89,304 shares of its common
Scholar Rock to Report First Quarter 2026 Financial Results on May 7, 2026
08:00am, Thursday, 16'th Apr 2026
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the financial markets open. The
SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug
01:40pm, Wednesday, 01'st Apr 2026
Scholar Rock stock jumps 14% after it resubmits its FDA filing for SMA drug apitegromab, revives approval hopes and sets up a potential September 2026 decision.
